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Intellectual disability (ID) has an estimated prevalence of 1.5%–2%. Whole exome
sequencing (WES) studies have identified a multitude of novel causative gene defects
and have shown that sporadic ID cases result from de novo mutations in genes asso-
ciated with ID. Here, we report on a 10-year-old girl, who has been regularly pres-
ented in our neuropediatric and genetic outpatient clinic. A median cleft palate and a
heart defect were surgically corrected in infancy. Apart from ID, she has behavioral
anomalies, muscular hypotonia, scoliosis, and hypermobile joints. The facial pheno-
type is characterized by arched eyebrows, mildly upslanting long palpebral fissures,
prominent nasal tip, and large, protruding ears. Trio WES revealed a de novo mis-
sense variant in MEIS2 (c.998G>A; p.Arg333Lys). Haploinsufficiency of MEIS2 had
been discussed as the most likely mechanism of the microdeletion 5q14-associated
complex phenotype with ID, cleft palate, and heart defect. Recently, four studies
including in total 17 individuals with intragenic MEIS2 variants were reported. Here
we present the evolution of the clinical phenotype and compare with the data of
known individuals.
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1 | INTRODUCTION
Intellectual disability (ID) has an estimated prevalence of 1.5%–2%
(Leonard & Wen, 2002). Whole exome sequencing (WES) studies have
identified a multitude of novel causative genetic variants and have
shown that a large proportion of sporadic ID cases in fact result from
de novo mutations with a constantly growing number of newly dis-
covered genes (Leonard & Wen, 2002).
In 2007, Erdogan and coworkers linked a patient presenting with
atrial septal defect type secundum (ASD II), cleft palate, moderate
developmental delay, severe speech delay, and mild motor delay to a
5.3 Mb deletion in 15q14 (Erdogan et al., 2007). In 2008 and 2010,
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two further patients with cleft palate and ventricle septal defect
(VSD) were identified, showing a deletion of 5.6 Mb and of 123 kb in
15q14, respectively (Chen et al., 2008; Crowley et al., 2010).
Notably, the only gene affected in all patients wasMEIS2, strongly
indicating that heterozygous loss of MEIS2 as cause for the clinical
manifestation of cleft palate, cardiac septal defects, and varying
degrees of developmental delay. In 2014, Johansson and colleagues
added nine more patients with MEIS2 mutations (five deletions and
four duplications) to the growing list of cases, validating the clinical
spectrum with clefting (7/9), ventricular septal defects (3/9), delayed
motor development, and learning disability (9/9), but not showing
consistent facial dysmorphisms (Johansson et al., 2014). Shortly after,
a one nucleotide deletion (c.998_1000del; p.Arg333del) within MEIS2
was published, identified in a girl with cleft palate, congenital heart
defect and further associated findings including feeding problems,
facial dysmorphism, severely delayed development and autism
spectrum disorder (Louw et al., 2015) supporting the concept of
MEIS2 as a gene causative for this complex phenotype. Three further
independent individuals with MEIS2 variants were reported—a girl
with severe ID, cleft palate, cardiac septal defect, and severe feeding
difficulties (c.611C>G, p.Ser204*) (Fujita et al., 2016); a girl with clini-
cal diagnosis of Rett syndrome but negative MECP2 analysis
(c.955A>G, p.Arg319Gly) (Srivastava et al., 2018); and a patient with
ID, absent speech, epilepsy, facial dysmorphism, larynx malposition,
and congenital heart defect diagnosed with a balanced chromosomal
rearrangement [t(11;15)([p14;q14)] causing a disruption of MEIS2
(Schluth-Bolard et al., 2019). Recently, four studies were published
including in total 17 individuals with pathogenic variants leading to
haploinsufficiency of MEIS2. Remarkably, MEIS2 haploinsufficiency
has been discussed as the most likely mechanism of the microdeletion
15q14-associated complex phenotype with ID, cleft palate, and heart
defect (Douglas et al., 2018; Giliberti et al., 2020; Hildebrand
et al., 2020; Verheije et al., 2019), thus adding MEIS2 to the growing
number of genes underlying syndromal ID. However, until now, no
studies presenting longitudinal data of the evolving phenotype have
been published.
2 | CLINICAL REPORT
The patient described in this report is the second born child of
healthy, unrelated parents of Caucasian descent. Family history
was unremarkable (the 4 years older sister is healthy and nor-
mally developed). The patient was clinically investigated over a
decade:
2.1 | 0–4 weeks (newborn)
Pregnancy was uneventful and spontaneous delivery was at term with
normal birth measurements. Postnatally, the patient developed a new-
born sepsis due to beta-hemolytic streptococci, no further informa-
tion available.
2.2 | 1–12 months of age (infant)
A median cleft palate was supplied with a plate and adjusted regularly.
Due to feeding difficulties (problems to suck and to swallow) and
resulting dystrophy (−2.5z at the age of 4 months), the infant formula
(“Pre-nutrition”) was enriched with rapeseed oil. A VSD and an ASD
were surgically corrected at 12 months of age.
2.3 | 1–2 years of age (toddler)
The patient developed tracheomalacia (including stenosis of left main
bronchus) causing recurrent pulmonary infections. The median cleft pal-
ate was surgically corrected at 1 5/12 years of age. Her psychomotor
development was significantly delayed (sitting independently with
21 months, crawling with 24 months) and was confirmed by assess-
ment of motor, speech, and cognitive development (“Münchener
Funktionelle Entwicklungsdiagnostik” [MFED]) at 2 6/12 years. Due to
the severe developmental delay noted in the MFED, Bayley-Scales of
Infant Development II were performed complementary at 2 11/12 years
of age and showed a cognitive-verbal developmental age of 13 months
and motor developmental age of 10 months. Facial dysmorphism
included protruding ears and thin arched eyebrows (Figure 1(a)).
2.4 | 3–5 years of age (pre-schooler)
Feeding problems and dystrophy persisted (−2.9z at the age of
3.5 years). Motor and speech development remained severely delayed,
but a slow developmental progress was reported by the parents. Inde-
pendent walking was achieved at 4 years and first words were spoken
at 5 years. At the age of 5.5 years, a further Bayley-Scales of Infant
Development II was performed (SON-R was not possible to be per-
formed) revealing a delay of minimum 3.5 years (cognitive-verbal devel-
opmental age of 22 months, motor developmental age of 18 months).
Apart from ID, behavioral problems such as (auto-)aggression and lack
of distance were noticed. The large protruding ears and thin arched
eyebrows appeared more evident (Figure 1(b)).
2.5 | 6–10 years of age (school-aged child)
The patient was externally diagnosed with infantile autism using the
ADI-R (diagnostic interview for autism) and the ADOS-G (standardized
observation scale for autistic disorders). Her increasingly aggressive
behavior required a medication with risperidone since the age of
7 years. Toilet training and threat awareness were not age-appropriate.
She was only able to speak few words and some simple 2–3-word sen-
tences. Another MFED performed at 9 10/12 revealed an overall devel-
opmental age of 34 months. Her posture was dominated by muscular
hypotonia, hypermobile joints, and a mild right convex thoracic scoliosis
(Figure 1(f), (g)) with a Cobb angle of 22 (Figure 1(h)) requiring a gum-
med brace. Her facial dysmorphisms became more evident over time,
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characterized by thin and arched eyebrows, thin lip vermillion and
prominent nasal tip with short alae nasi, and large, protruding ears with
enlarged fossa triangularis and hypoplastic antihelix (Figure 1(a)–(f)).
Growth parameters at 9 10/12 years of age were weight 23.4 kg (2nd
percentile, −2.12z); height 125.9 cm (1st percentile, −2.19z); head cir-
cumference 50 cm (1st percentile, −1.9z); BMI 14.8 kg/m2 (15th per-
centile, −1.05z). For the course of growth parameters see Figure 2.
3 | MATERIALS AND METHODS
3.1 | Editorial policies and ethical considerations
All data concerning our patient was extracted from her medical rou-
tine files. This approach was approved by our local ethics committee.
For all diagnostic steps, written informed consent was obtained from
both parents. The permission to publish clinical data and photos was
obtained from her father (now sole custodian). The study was con-
ducted in accordance with the principles of the Declaration of Hel-
sinki. The data that support the findings of this study are available
from the corresponding author upon reasonable request.
3.2 | Genetic analyses
First, regular karyotyping followed by microarray analysis were per-
formed. As the girl's clinical and phenotypic features showed some
overlap with those present in Kabuki's syndrome (ID, congenital heart
defects, low measurements, facial phenotype with high arched eye-
brows and ear deformities), analyses of KMT2D and KDM6A were
F IGURE 1 Clinical presentation of our MEIS2 patient: (a) At age of 2 5/12 years with large protruding ears and thin arched eyebrows. (b) At
the age of 6 6/12 and (c, e) 8 7/12 years with more distinctive facial dysmorphism and muscle hypotonia. (d, f, g) At the age of 9 10/12 years facial
features, such as thin and arched eyebrows, thin lip vermillion and prominent nasal tip with short alae nasi, and large, protruding ears with
enlarged fossa triangularis and hypoplastic antihelix, are evident. (f, g) In addition to the evolving facial phenotype and muscle hypotonia, the
patient developed hypermobile joints and scoliosis. (h) Standing/sitting x-ray of the thorax showing a right convex thoracic scoliosis with Cobb
angle of 22 and mild rotation component [Color figure can be viewed at wileyonlinelibrary.com]
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carried out as a second step. Third, trio analysis by exome analysis
was conducted. For variant analysis CCG varbank (https://varbank.
ccg.uni-koeln.de/) was used. For confirmation, polymerase chain reac-
tion (PCR) and Sanger sequencing of exon 10 including flanking intron
sequences of MEIS2 gene (OMIM 601740) were performed.
4 | RESULTS
Regular karyotyping was normal. Microarray analysis showed a partial
deletion in ITPR2, which was further defined as inherited benign
familial variant. Molecular genetic analyses of KMT2D and KDM6A
showed no pathological findings, making Kabuki syndrome (MIM
#147920 and #300867) unlikely. Trio exome sequencing revealed a
heterozygous de novo missense variant (c.998G>A, p.Arg333Lys;
RefSeq NM_170674.4) in MEIS2 (MIM *601740) located on chromo-
some 15q14. Subsequent Sanger sequencing of exon 10 of MEIS2
gene confirmed the findings of exome analysis. This variant was
predicted in silico to be damaging/deleterious/disease causing
(PolyPhen2/SIFT/Mutation Taster) with a CADD score of 28.7 and
was absent in the GnomAD database (http://gnomad.broadinstitute.
org/).
F IGURE 2 Course of growth parameters: (a) head circumference, (b) body height, (c) body weight. Standard deviations of each measurement
indicated as z-score. Percentiles from: Referenzperzentile für anthropometrische Maßzahlen und Blutdruck aus der Studie zur Gesundheit von
Kindern und Jugendlichen in Deutschland (KIGGS), Robert-Koch-Institut 2013, 2. Auflage, ISBN 978-3-89606-218-5. Created with: Ped(z)-
Kinderarztrechner (www.pedz.de)
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5 | DISCUSSION
Here, we report the seventh patient with a missense mutation in
MEIS2 leading to syndromic ID associated with craniofacial dys-
morphism, cleft palate, and congenital heart defect. One patient
with the identical missense variant (c.998G>A, p.Arg333Lys) was
described only very recently by Verheije et al. (2019). This patient
presented with ASD and VSD, profound developmental delay, and
facial dysmorphism but also additional duodenal stenosis, hypothy-
roidism, transitory pancreatitis, nephrocalcinosis, bilateral inguinal
hernia, stenosis of the left lower pulmonary vein, and persisting
respiratory insufficiency leading to tracheotomy at the age of
11 months and his early death at the age of 13 months. Due to the
patient's severe phenotype and atypical features, a multilocal geno-
mic variation was assumed. Indeed, exome sequencing of this
patient also revealed a de novo intragenic 185-bp deletion of FOXP1
and compound heterozygosity for rare variants in the LRP2 gene
(Verheije et al., 2019). This complex genotype might explain the dif-
ferences in genotype–phenotype correlation of our patient in com-
parison to the patient described by Verheije et al. (2019). Moreover,
comparison of clinical features and genetic findings of these two
cases emphasizes the relevance of combining and considering all
patient data to describe unambiguous phenotypes enabling a “clini-
cal refinement” as provided by our case for the first time for patho-
genic MEIS2 missense variants.
Pulmonary symptoms as described in our patient with severe
tracheomalacia including stenosis of left main bronchus causing multi-
ple pulmonary infections are so far not described as typical for
patients with MEIS2 mutations. However, in two further MEIS2
patients similar findings were observed before: one female patient
described by Louw and colleagues in 2015 with a small de novo in-
frame deletion (c.998_1000del; p.Arg333del) affecting the same
amino acid as in our patient, showed congenital lobar emphysema of
the left upper lobe (Louw et al., 2015). In 2019, Verheije and col-
leagues described in the already above-mentioned patient persisting
pulmonary insufficiency leading to tracheotomy at the age of
11 months and early death at the age of 13 months.
As shown in Figure 1, the “MEIS2 phenotype” evolves and
becomes more evident over time. Up to now, 49 patients carrying
pathogenic MEIS2 variants were described in literature (Giliberti
et al., 2020; Hildebrand et al., 2020). Our case is the seventh patient
presenting with a pathogenic MEIS2 missense variant. Comparison
with the one individual known to carry the identical MEIS2 missense
mutation but also additional sequence variants allows a clinical refine-
ment which supports the concept that pulmonary problems might be
(a less frequent) feature of this syndromic MEIS2 phenotype.
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